Application of Automatic Biochemical and Blood Analyzer in the Third Trimester of Pregnant Women with Diabetes
Objective:To explore the clinical value of automatic biochemical analyzer and blood analyzer in the third trimester of pregnancy with diabetes mellitus(GDM).Methods:60 pregnant women with advanced gestational diabetes mellitus(GDM)who were admitted from September 2020 to September 2023 were selected as the observation group.60 normal pregnant women admitted during the same period were randomly selected as the reference group.The blood lipids of the two groups of pregnant women were measured using a fully automated biochemical analyzer and a blood analyzer,respectively,including total cholesterol(TC),triglycerides(TG),high-density lipoprotein(HDL-C),and low-density lipoprotein(LDL-C)coagulation function[D-dimer(D-D),hematocrit(HCT),platelet count(BPC),fibrinogen(Fbg)]detection,analysis and comparison of blood lipids,coagulation function indicators,and pregnancy outcomes between two groups of pregnant women.Results:There was no significant difference in BPC indicators between the two groups of pregnant women(P>0.05).The levels of TC,TG,HCT,Fbg,D-D,LDL-C,and incidence of adverse pregnancy outcomes were higher in the observation group compared to the reference group,but their HDL-C levels were lower than those in the reference group(P<0.05).Conclusion:The use of fully automated biochemical analyzers and blood analyzers to detect GDM in late pregnancy can clearly indicate the presence of hyperlipidemia,hypercoagulability,and pre thrombotic status,and can easily lead to adverse pregnancy outcomes in pregnant women.Therefore,we should pay attention to monitoring the blood lipid and coagulation function indicators of pregnant women with diabetes in the third trimester of pregnancy,and implement effective intervention measures for pregnant women to improve the abnormal phenomenon of blood lipid and coagulation function of pregnant women and ensure the pregnancy outcome of pregnant women.